CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$220,984
-37.0%
96,0800.0%0.00%
Q2 2023$350,692
+276.6%
96,080
+268.3%
0.00%
Q1 2023$93,120
+158.3%
26,084
+106.2%
0.00%
Q4 2022$36,058
+24.3%
12,6520.0%0.00%
Q3 2022$29,000
-9.4%
12,6520.0%0.00%
Q2 2022$32,000
-91.9%
12,652
-84.4%
0.00%
Q1 2022$396,000
-56.8%
81,0500.0%0.00%
Q4 2021$917,000
-19.6%
81,050
+3.6%
0.00%
Q3 2021$1,140,000
-51.0%
78,230
-60.8%
0.00%
-100.0%
Q2 2021$2,325,000
-1.1%
199,560
+3.6%
0.00%0.0%
Q1 2021$2,351,000
+1.9%
192,667
+4.5%
0.00%0.0%
Q4 2020$2,308,000
-19.6%
184,421
-3.2%
0.00%0.0%
Q3 2020$2,869,000
+32.0%
190,615
+115.0%
0.00%0.0%
Q2 2020$2,174,000
+204.1%
88,659
+76.0%
0.00%
Q1 2020$715,000
-10.3%
50,387
+0.4%
0.00%
Q4 2019$797,000
+93.9%
50,192
+3.2%
0.00%
Q3 2019$411,000
-0.2%
48,646
+6.2%
0.00%
Q2 2019$412,000
+16.1%
45,8090.0%0.00%
Q1 2019$355,000
+127.6%
45,809
+38.4%
0.00%
Q4 2018$156,000
-48.0%
33,1000.0%0.00%
Q3 2018$300,000
-23.7%
33,1000.0%0.00%
Q2 2018$393,000
+70.9%
33,100
+103.1%
0.00%
Q1 2018$230,00016,3000.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,915,219$23,959,0005.70%
Prosight Management, LP 906,569$11,341,0005.24%
P.A.W. CAPITAL CORP 140,000$1,751,0001.54%
Voss Capital, LLC 220,714$2,761,0001.39%
Robertson Stephens Wealth Management, LLC 484,000$6,054,0001.26%
Slate Path Capital LP 1,483,619$18,560,0001.00%
Nantahala Capital Management 2,506,772$31,360,0000.97%
PRECEPT MANAGEMENT LLC 150,000$1,877,0000.76%
SANDERS MORRIS HARRIS LLC 193,591$2,449,0000.56%
Rock Creek Group, LP 100,014$1,251,0000.51%
View complete list of CUE BIOPHARMA INC shareholders